ConferenceCirculation · November 4, 2025
Introduction:
The burden of acute myocardial infarction (AMI) is growing in Tanzania, but AMI is frequently misdiagnosed, and uptake of evidence-based AMI care is suboptimal, leading t ...
Full textCite
ConferenceCirculation · November 4, 2025
Background:
Moderate to severe left ventricular dysfunction (LVD), defined by a left ventricular ejection fraction (LVEF) <40%, is a key marker of heart failure with reduced ejectio ...
Full textCite
ConferenceCirculation · November 12, 2024
Introduction:
With effective antiretroviral therapy (ART), HIV can now be managed as a chronic disease. Chronic disease and cardiovascular risk factor management is especially important for underrepre ...
Full textCite
ConferenceCirculation · March 19, 2024
Background:
People with HIV (PWH) are at elevated atherosclerotic cardiovascular disease (ASCVD) risk. Underrepresented racial and ethnic groups (UREGs) with HIV in the Southern U.S. are disproportion ...
Full textCite
ConferenceStroke · March 2021
Background:
Mobile Cardiac outpatient telemetry (MCOT) is often used for patients (pts) with cryptogenic ischemic stroke following hospital discharge to detect atrial fibrillation (AFib) but criteria ...
Full textCite
ConferenceCirculation · November 17, 2020
Background:
Cardiac rehabilitation (CR) is an evidence based, cost effective treatment for heart failure (HF). Globally, access to CR is limited, especially in low- and middle-income countries. An int ...
Full textCite
ConferenceCirculation · March 5, 2019
Background:
Heart failure (HF) is a growing driver of morbidity and mortality worldwide. Cardiac rehabilitation in HF improves functional status, quality of life, and depression. Global access to card ...
Full textCite